Frontlight ResearchEarly access
Cystic fibrosis trials in China
8 of 11 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Not yet taking people in ChinaA Study of RSS0343 Tablets in Healthy Participants and in Participants With Mild or Moderate Renal Impairment
- Where
- Zhengzhou
- Age
- 18 years to 65 years
- People
- 24
- Run by
- Reistone Biopharma Company Limited
See details and how to joinNCT07940829 - Phase 1Taking peopleInvestigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal Impairment
- Where
- Zhenzhou
- Age
- 18 years to 70 years
- People
- 24
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07915011 - Phase 1Taking peopleInvestigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Hepatic Impairment
- Where
- Zhenzhou
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07913009 - Early phase 1Taking peopleSafety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years
- Where
- Beijing
- Age
- 12 years and over
- People
- 24
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07485543 - Phase 1Not yet taking people in ChinaStudy on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet
- Where
- Guangzhou
- Age
- 18 years to 55 years
- People
- 40
- Run by
- Reistone Biopharma Company Limited
See details and how to joinNCT07696091 - Phase 3Taking peopleA Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
- Where
- Yixingcun
- Age
- 18 years and over
- People
- 669
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07616375 - Phase 2Taking peopleStudy of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 252
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT06775340 - Phase 3Taking peopleA Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
- Where
- Guangzhou, Yixingcun
- Age
- 18 years and over
- People
- 669
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06660992